482 related articles for article (PubMed ID: 18713156)
1. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
4. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
5. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
[TBL] [Abstract][Full Text] [Related]
7. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
8. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
Afshari D; Rafizadeh S; Rezaei M
Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
[TBL] [Abstract][Full Text] [Related]
10. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
Gupta P; Singh S; Goyal V; Shukla G; Behari M
Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
[TBL] [Abstract][Full Text] [Related]
11. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
12. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
13. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
14. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
15. Topiramate as an adjunctive treatment in migraine prophylaxis.
Martínez HR; Londoño O; Cantú-Martínez L; del Carmen Tarín L; Castillo CD
Headache; 2003; 43(10):1080-4. PubMed ID: 14629243
[TBL] [Abstract][Full Text] [Related]
16. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
Brandes JL; Kudrow DB; Rothrock JF; Rupnow MF; Fairclough DL; Greenberg SJ
Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
[TBL] [Abstract][Full Text] [Related]
17. Clinical assessment of topiramate therapy in patients with migrainous vertigo.
Gode S; Celebisoy N; Kirazli T; Akyuz A; Bilgen C; Karapolat H; Sirin H; Gokcay F
Headache; 2010 Jan; 50(1):77-84. PubMed ID: 19656221
[TBL] [Abstract][Full Text] [Related]
18. Topiramate: new indication. Migraine prevention: best avoided.
Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
[TBL] [Abstract][Full Text] [Related]
19. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
[TBL] [Abstract][Full Text] [Related]
20. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
Keskinbora K; Aydinli I
Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]